[Retracted] Analysis of Prevalence, Influencing Factors, and Countermeasures of Short Stature in Children and Adolescents Aged 6∼14 in Furong District, Changsha City, in 2020

Table 3

Univariate analysis of occurrence of short stature.

Clinical information	Diseased group (n = 1517)	Nondiseased group (n = 52255)	χ^2/t	value
Gender
Male	750 (49.44)	27817 (53.23)	8.938	0.003
Female	767 (50.56)	24348 (46.59)
Age (years old)	9.41 ± 2.31	9.36 ± 2.39	0.804	0.421
Growth hormone level
＜10 μg/L	1026 (67.63)	12109 (23.17)	1578.586	0.000
≥10 μg/L	491 (32.37)	40146 (76.83)
Pubertal retardation
Yes	1043 (68.75)	10374 (19.85)	21007.933	0.000
No	474 (31.25)	41881 (80.15)
Intrauterine growth retardation
Yes	59 (3.89)	2103 (4.02)	0.070	0.792
No	1458 (96.11)	50152 (95.98)
Hypothyroidism
Yes	549 (36.19)	65989 (12.63)	710.231	0.000
No	968 (63.81)	45657 (87.37)
Turner syndrome
Yes	161 (10.61)	1173 (2.24)	426.718	0.000
No	1356 (89.39)	51082 (97.76)
Familial short stature
Yes	992 (65.39)	6149 (11.77)	3681.029	0.000
No	525 (34.61)	46106 (88.23)
Paternal height	156.56 ± 14.37	173.41 ± 16.79	38.679	0.000
Maternal height	150.36 ± 10.12	150.42 ± 10.69	0.216	0.829
Egg intake
Occasionally or not	571 (37.64)	3054 (5.84)	2791.266	0.000
Less than once a week	454 (29.93)	8616 (16.49)
1–2 times a week	296 (19.51)	17119 (32.76)
3–5 times a week	196 (12.92)	23466 (44.91)
Daily milk intake
＜250 mL	491 (32.37)	17471 (33.43)	4.590	0.101
250–500 mL	546 (35.99)	17440 (33.37)
＞500 mL	480 (31.64)	17344 (33.19)
Exercise status
Never	175 (11.54)	5413 (10.36)	39.989	0.000
≤1 times	378 (24.92)	9946 (19.03)
2–3 times	426 (28.08)	15679 (30.00)
≥4 times	538 (35.46)	21217 (40.60)